We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The new recognition routes open additional options for the MHRA to bring cutting-edge medicines faster to UK patients by leveraging the expertise and decision-making of trusted regulatory partners
UK government announces up to £39 million cash injection for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF).
First published during the 2022 to 2024 Sunak Conservative government
Health and Social Care Secretary Steve Barclay delivered a speech to the Association of the British Pharmaceutical Industry (ABPI) annual conference.
Sir Hugh Taylor has been appointed as Chief Negotiations Adviser for the voluntary scheme for branded medicines pricing and access (VPAS).
The legislative changes will help to make the UK one of the best countries in the world to conduct clinical research for patients and researchers.
The UK Government has named two leaders in dementia research to spearhead the ambitious national Mission to tackle dementia.
The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.
HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.
Today (Monday 6 March) the Women’s and Health Minister, Maria Caulfield met leading researchers and discussed their work to improve health outcomes for women and babies, and the importance of women working in STEM (science, …
The 2023 England Rare Diseases Action Plan goes further than ever before to support people living with rare diseases.
New Leeds Health and Social Care Hub will bring together local organisations to improve health outcomes for patients.
First published during the 2019 to 2022 Johnson Conservative government
Health and Social Care Secretary Steve Barclay met with researchers, charities and patients to discuss finding a cure for motor neurone disease following £50 million funding.
The medical technology strategy will ensure patients can access safe, effective and innovative equipment and medical devices.
The establishment of a regulatory framework for POC manufacturing would bring a range of benefits to patients, healthcare professionals and innovators.
UK signs memorandum of understanding with Thailand to boost genomics expertise and explore mutual priorities for improving patient outcomes.
New cancer trials to begin using personalised treatment to save lives.
Government announces funding to create the most advanced genomic healthcare system in the world, helping to save lives and improve health outcomes.
Red tape will be cut to speed up research into motor neurone disease (MND) across the UK, enabling faster progress towards treatments.
The government is setting up an Elective Recovery Taskforce to help the NHS deliver on waiting list targets, bringing together a range of healthcare experts.
Speech by Health and Social Care Secretary Steve Barclay at the Spectator Health Summit in London.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).